Acri-Phase I, LLC   Report issue

For profit Phase 3
Founded: Anaheim CA United States (2008)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2011
NCT01461369
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

ACRI-Phase I, LLC

Active Ingredients

Drugs in Phase 3 Trials (1)

diclofenac (voltaren) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1